Will only rich countries be able to get this corona vaccine?

0
Israel claims on Corona Vaccine

New Delhi: Pfizer Inc. and BioNTech SE, which claim a 90 percent effectiveness against the coronavirus, will complete the next phase when the Covid-19 is ready, followed by Shanghai Fosun Pharmaceutical Group Company. Shanghai Fosun Pharmaceutical Group Company). The company will distribute the vaccine in China through a complex and expensive system through deep freeze airport warehouses, refrigerated trains, and vaccination points. According to the report of Times of India, after reaching the vaccination centers, these shots have to be kept at a temperature of -70 degrees Celsius and if they do not deteriorate, they have to be given to the people within 5 days. Then this laborious process of vaccination given to the people from the warehouse freezer has to be done again after one month.

Pfizer-Inc.-and-BioNTech-SE-1

This roadmap has been prepared by a licensing company for Greater China. Which presents a glimpse of the huge and challenging logistical challenges in delivering Pfizer’s experimental vaccine, which showed “exceptional” initial results for final-stage tests. This is expected to end almost a year after the onset of the epidemic. So far no vaccine has been developed like Pfizer that uses RNA technology. This allows the human body to produce proteins that later develop protective antibodies.

Only rich countries will have access?
This means that countries must build the deep-freeze production, storage, and transportation networks needed for the vaccine to survive. It requires a lot of investment and coordination, but it also shows that it can only reach the rich countries and that too only their urban population.

Ding Sheng, director of the Global Health Drug Discovery Institute in Beijing, which is funded by the Melinda Gates Foundation, said, “Its production is expensive, its components are unstable. It also requires cold-chain transportation and has a short shelf life. . “

The cost of the Pfizer shot will reinforce existing fears that rich countries will already get the best vaccine. Despite the World Health Organization-supported effort CoVAX, which aims to raise 18 18 billion to buy vaccines for poor countries.

Advertisement